 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C19H25NS |
| Molar mass | 299.48 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Benocyclidine, also known asbenzo
It acts as apotent andselectivedopamine reuptake inhibitor (DRI) and apsychostimulant.[2][3] Unlike relatedcompounds likephencyclidine andketamine, benocyclidine is a pure DRI with negligibleaffinity for theNMDA receptor, and it therefore lacks anyanticonvulsant,anesthetic,hallucinogenic, ordissociative effects.[2][3] It has been used to label thedopamine transporter.[4][5] BCP was used to try to find a commonpharmacophore for DRI type stimulants.[6]
More recently, benocyclidine has been found in several ecstasy tablets, sold asMDMA.[7]
Benocyclidine is a Schedule Icontrolled substance in the state ofFlorida andVirginia, making it illegal to buy, sell, or possess in these states.[8][9]
Otherwise, benocyclidine is not scheduled at the federal level in theUnited States,[10] but may be considered an analog of PCP, in which case purchase, sale, or possession could be prosecuted under theFederal Analog Act if intended for human consumption.
